位置:首页 > 蛋白库 > ATS15_HUMAN
ATS15_HUMAN
ID   ATS15_HUMAN             Reviewed;         950 AA.
AC   Q8TE58; Q32MI6;
DT   28-FEB-2003, integrated into UniProtKB/Swiss-Prot.
DT   01-JUN-2002, sequence version 1.
DT   03-AUG-2022, entry version 164.
DE   RecName: Full=A disintegrin and metalloproteinase with thrombospondin motifs 15;
DE            Short=ADAM-TS 15;
DE            Short=ADAM-TS15;
DE            Short=ADAMTS-15;
DE            EC=3.4.24.-;
DE   Flags: Precursor;
GN   Name=ADAMTS15;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND TISSUE SPECIFICITY.
RX   PubMed=11867212; DOI=10.1016/s0378-1119(01)00861-7;
RA   Cal S., Obaya A.J., Llamazares M., Garabaya C., Quesada V., Lopez-Otin C.;
RT   "Cloning, expression analysis, and structural characterization of seven
RT   novel human ADAMTSs, a family of metalloproteinases with disintegrin and
RT   thrombospondin-1 domains.";
RL   Gene 283:49-62(2002).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [3]
RP   VARIANTS [LARGE SCALE ANALYSIS] ARG-770 AND GLY-878.
RX   PubMed=16959974; DOI=10.1126/science.1133427;
RA   Sjoeblom T., Jones S., Wood L.D., Parsons D.W., Lin J., Barber T.D.,
RA   Mandelker D., Leary R.J., Ptak J., Silliman N., Szabo S., Buckhaults P.,
RA   Farrell C., Meeh P., Markowitz S.D., Willis J., Dawson D., Willson J.K.V.,
RA   Gazdar A.F., Hartigan J., Wu L., Liu C., Parmigiani G., Park B.H.,
RA   Bachman K.E., Papadopoulos N., Vogelstein B., Kinzler K.W.,
RA   Velculescu V.E.;
RT   "The consensus coding sequences of human breast and colorectal cancers.";
RL   Science 314:268-274(2006).
CC   -!- FUNCTION: Metalloprotease which has proteolytic activity against the
CC       proteoglycan VCAN, cleaving it at the 'Glu-1428-|-1429-Ala' site.
CC       Cleaves VCAN in the pericellular matrix surrounding myoblasts,
CC       facilitating myoblast contact and fusion which is required for skeletal
CC       muscle development and regeneration. {ECO:0000250|UniProtKB:P59384}.
CC   -!- COFACTOR:
CC       Name=Zn(2+); Xref=ChEBI:CHEBI:29105;
CC         Evidence={ECO:0000250|UniProtKB:Q9UHI8};
CC       Note=Binds 1 zinc ion per subunit. {ECO:0000250|UniProtKB:Q9UHI8};
CC   -!- SUBCELLULAR LOCATION: Secreted, extracellular space, extracellular
CC       matrix {ECO:0000250|UniProtKB:P59384}. Cell surface
CC       {ECO:0000250|UniProtKB:P59384}.
CC   -!- TISSUE SPECIFICITY: Expressed in fetal liver and kidney, but not in any
CC       of the adult tissues examined. {ECO:0000269|PubMed:11867212}.
CC   -!- DOMAIN: The spacer domain and the TSP type-1 domains are important for
CC       a tight interaction with the extracellular matrix. {ECO:0000250}.
CC   -!- DOMAIN: The conserved cysteine present in the cysteine-switch motif
CC       binds the catalytic zinc ion, thus inhibiting the enzyme. The
CC       dissociation of the cysteine from the zinc ion upon the activation-
CC       peptide release activates the enzyme.
CC   -!- PTM: The precursor is cleaved by a furin endopeptidase.
CC       {ECO:0000250|UniProtKB:P59384}.
CC   -!- PTM: Glycosylated. Can be O-fucosylated by POFUT2 on a serine or a
CC       threonine residue found within the consensus sequence C1-X(2)-(S/T)-C2-
CC       G of the TSP type-1 repeat domains where C1 and C2 are the first and
CC       second cysteine residue of the repeat, respectively. Fucosylated
CC       repeats can then be further glycosylated by the addition of a beta-1,3-
CC       glucose residue by the glucosyltransferase, B3GALTL. Fucosylation
CC       mediates the efficient secretion of ADAMTS family members. Can be C-
CC       glycosylated with one or two mannose molecules on tryptophan residues
CC       within the consensus sequence W-X-X-W of the TPRs. Also N-glycosylated.
CC       These other glycosylations can also facilitate secretion.
CC       {ECO:0000250|UniProtKB:Q76LX8}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AJ315733; CAC86014.1; -; mRNA.
DR   EMBL; BC109114; AAI09115.1; -; mRNA.
DR   CCDS; CCDS8488.1; -.
DR   RefSeq; NP_620686.1; NM_139055.3.
DR   AlphaFoldDB; Q8TE58; -.
DR   SMR; Q8TE58; -.
DR   BioGRID; 128081; 8.
DR   STRING; 9606.ENSP00000299164; -.
DR   MEROPS; M12.025; -.
DR   GlyGen; Q8TE58; 4 sites.
DR   iPTMnet; Q8TE58; -.
DR   PhosphoSitePlus; Q8TE58; -.
DR   BioMuta; ADAMTS15; -.
DR   DMDM; 48474504; -.
DR   jPOST; Q8TE58; -.
DR   MassIVE; Q8TE58; -.
DR   MaxQB; Q8TE58; -.
DR   PaxDb; Q8TE58; -.
DR   PeptideAtlas; Q8TE58; -.
DR   PRIDE; Q8TE58; -.
DR   ProteomicsDB; 74400; -.
DR   Antibodypedia; 33110; 143 antibodies from 20 providers.
DR   DNASU; 170689; -.
DR   Ensembl; ENST00000299164.4; ENSP00000299164.2; ENSG00000166106.4.
DR   GeneID; 170689; -.
DR   KEGG; hsa:170689; -.
DR   MANE-Select; ENST00000299164.4; ENSP00000299164.2; NM_139055.4; NP_620686.1.
DR   UCSC; uc010scd.3; human.
DR   CTD; 170689; -.
DR   DisGeNET; 170689; -.
DR   GeneCards; ADAMTS15; -.
DR   HGNC; HGNC:16305; ADAMTS15.
DR   HPA; ENSG00000166106; Tissue enhanced (adipose).
DR   MIM; 607509; gene.
DR   neXtProt; NX_Q8TE58; -.
DR   OpenTargets; ENSG00000166106; -.
DR   PharmGKB; PA24541; -.
DR   VEuPathDB; HostDB:ENSG00000166106; -.
DR   eggNOG; KOG3538; Eukaryota.
DR   GeneTree; ENSGT00940000155801; -.
DR   HOGENOM; CLU_000660_3_0_1; -.
DR   InParanoid; Q8TE58; -.
DR   OMA; HNLNKYR; -.
DR   OrthoDB; 125522at2759; -.
DR   PhylomeDB; Q8TE58; -.
DR   TreeFam; TF331949; -.
DR   BRENDA; 3.4.24.B12; 2681.
DR   PathwayCommons; Q8TE58; -.
DR   Reactome; R-HSA-5083635; Defective B3GALTL causes PpS.
DR   Reactome; R-HSA-5173214; O-glycosylation of TSR domain-containing proteins.
DR   BioGRID-ORCS; 170689; 7 hits in 1069 CRISPR screens.
DR   ChiTaRS; ADAMTS15; human.
DR   GenomeRNAi; 170689; -.
DR   Pharos; Q8TE58; Tbio.
DR   PRO; PR:Q8TE58; -.
DR   Proteomes; UP000005640; Chromosome 11.
DR   RNAct; Q8TE58; protein.
DR   Bgee; ENSG00000166106; Expressed in decidua and 120 other tissues.
DR   Genevisible; Q8TE58; HS.
DR   GO; GO:0009986; C:cell surface; IEA:UniProtKB-SubCell.
DR   GO; GO:0062023; C:collagen-containing extracellular matrix; IEA:InterPro.
DR   GO; GO:0031012; C:extracellular matrix; IBA:GO_Central.
DR   GO; GO:0005615; C:extracellular space; IEA:Ensembl.
DR   GO; GO:0004175; F:endopeptidase activity; ISS:UniProtKB.
DR   GO; GO:0050840; F:extracellular matrix binding; IEA:Ensembl.
DR   GO; GO:0008201; F:heparin binding; IEA:Ensembl.
DR   GO; GO:0004222; F:metalloendopeptidase activity; IBA:GO_Central.
DR   GO; GO:0008270; F:zinc ion binding; IEA:InterPro.
DR   GO; GO:0022617; P:extracellular matrix disassembly; ISS:UniProtKB.
DR   GO; GO:0030198; P:extracellular matrix organization; IBA:GO_Central.
DR   GO; GO:0007520; P:myoblast fusion; ISS:UniProtKB.
DR   GO; GO:0006508; P:proteolysis; IEA:UniProtKB-KW.
DR   Gene3D; 2.20.100.10; -; 3.
DR   Gene3D; 3.40.390.10; -; 1.
DR   InterPro; IPR006586; ADAM_Cys-rich.
DR   InterPro; IPR013273; ADAMTS/ADAMTS-like.
DR   InterPro; IPR041645; ADAMTS_CR_2.
DR   InterPro; IPR045371; ADAMTS_CR_3.
DR   InterPro; IPR010294; ADAMTS_spacer1.
DR   InterPro; IPR024079; MetalloPept_cat_dom_sf.
DR   InterPro; IPR013277; Pept_M12B_ADAM-TS8.
DR   InterPro; IPR001590; Peptidase_M12B.
DR   InterPro; IPR002870; Peptidase_M12B_N.
DR   InterPro; IPR000884; TSP1_rpt.
DR   InterPro; IPR036383; TSP1_rpt_sf.
DR   Pfam; PF17771; ADAM_CR_2; 1.
DR   Pfam; PF19236; ADAM_CR_3; 1.
DR   Pfam; PF05986; ADAM_spacer1; 1.
DR   Pfam; PF01562; Pep_M12B_propep; 1.
DR   Pfam; PF01421; Reprolysin; 1.
DR   Pfam; PF00090; TSP_1; 1.
DR   PRINTS; PR01861; ADAMTS8.
DR   PRINTS; PR01857; ADAMTSFAMILY.
DR   SMART; SM00608; ACR; 1.
DR   SMART; SM00209; TSP1; 3.
DR   SUPFAM; SSF82895; SSF82895; 3.
DR   PROSITE; PS50215; ADAM_MEPRO; 1.
DR   PROSITE; PS50092; TSP1; 3.
DR   PROSITE; PS00142; ZINC_PROTEASE; 1.
PE   2: Evidence at transcript level;
KW   Cleavage on pair of basic residues; Disulfide bond; Extracellular matrix;
KW   Glycoprotein; Hydrolase; Metal-binding; Metalloprotease; Protease;
KW   Reference proteome; Repeat; Secreted; Signal; Zinc; Zymogen.
FT   SIGNAL          1..17
FT                   /evidence="ECO:0000255"
FT   PROPEP          18..212
FT                   /evidence="ECO:0000250|UniProtKB:P59384"
FT                   /id="PRO_0000029192"
FT   CHAIN           213..950
FT                   /note="A disintegrin and metalloproteinase with
FT                   thrombospondin motifs 15"
FT                   /id="PRO_0000029193"
FT   DOMAIN          218..427
FT                   /note="Peptidase M12B"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00276"
FT   DOMAIN          428..515
FT                   /note="Disintegrin"
FT   DOMAIN          516..571
FT                   /note="TSP type-1 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00210"
FT   DOMAIN          839..895
FT                   /note="TSP type-1 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00210"
FT   DOMAIN          896..949
FT                   /note="TSP type-1 3"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00210"
FT   REGION          151..172
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          701..838
FT                   /note="Spacer"
FT   REGION          798..822
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOTIF           172..179
FT                   /note="Cysteine switch"
FT                   /evidence="ECO:0000250"
FT   COMPBIAS        799..815
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   ACT_SITE        362
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00276,
FT                   ECO:0000255|PROSITE-ProRule:PRU10095"
FT   BINDING         174
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_note="catalytic"
FT                   /note="in inhibited form"
FT                   /evidence="ECO:0000250"
FT   BINDING         361
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_note="catalytic"
FT                   /evidence="ECO:0000250"
FT   BINDING         365
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_note="catalytic"
FT                   /evidence="ECO:0000250"
FT   BINDING         371
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_note="catalytic"
FT                   /evidence="ECO:0000250"
FT   CARBOHYD        141
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        591
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        623
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        679
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   DISULFID        293..345
FT                   /evidence="ECO:0000250|UniProtKB:Q9UNA0"
FT   DISULFID        322..327
FT                   /evidence="ECO:0000250|UniProtKB:Q9UNA0"
FT   DISULFID        339..422
FT                   /evidence="ECO:0000250|UniProtKB:Q9UNA0"
FT   DISULFID        377..406
FT                   /evidence="ECO:0000250|UniProtKB:Q9UNA0"
FT   DISULFID        448..470
FT                   /evidence="ECO:0000250|UniProtKB:Q9UNA0"
FT   DISULFID        459..480
FT                   /evidence="ECO:0000250|UniProtKB:Q9UNA0"
FT   DISULFID        465..499
FT                   /evidence="ECO:0000250|UniProtKB:Q9UNA0"
FT   DISULFID        493..504
FT                   /evidence="ECO:0000250|UniProtKB:Q9UNA0"
FT   DISULFID        528..565
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00210"
FT   DISULFID        532..570
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00210"
FT   DISULFID        543..555
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00210"
FT   VARIANT         623
FT                   /note="N -> S (in dbSNP:rs11222114)"
FT                   /id="VAR_051594"
FT   VARIANT         770
FT                   /note="Q -> R (in a colorectal cancer sample; somatic
FT                   mutation; dbSNP:rs776537988)"
FT                   /evidence="ECO:0000269|PubMed:16959974"
FT                   /id="VAR_036150"
FT   VARIANT         878
FT                   /note="C -> G (in a colorectal cancer sample; somatic
FT                   mutation)"
FT                   /evidence="ECO:0000269|PubMed:16959974"
FT                   /id="VAR_036151"
SQ   SEQUENCE   950 AA;  103287 MW;  5DFBE18285CCCC3B CRC64;
     MLLLGILTLA FAGRTAGGSE PEREVVVPIR LDPDINGRRY YWRGPEDSGD QGLIFQITAF
     QEDFYLHLTP DAQFLAPAFS TEHLGVPLQG LTGGSSDLRR CFYSGDVNAE PDSFAAVSLC
     GGLRGAFGYR GAEYVISPLP NASAPAAQRN SQGAHLLQRR GVPGGPSGDP TSRCGVASGW
     NPAILRALDP YKPRRAGFGE SRSRRRSGRA KRFVSIPRYV ETLVVADESM VKFHGADLEH
     YLLTLLATAA RLYRHPSILN PINIVVVKVL LLRDRDSGPK VTGNAALTLR NFCAWQKKLN
     KVSDKHPEYW DTAILFTRQD LCGATTCDTL GMADVGTMCD PKRSCSVIED DGLPSAFTTA
     HELGHVFNMP HDNVKVCEEV FGKLRANHMM SPTLIQIDRA NPWSACSAAI ITDFLDSGHG
     DCLLDQPSKP ISLPEDLPGA SYTLSQQCEL AFGVGSKPCP YMQYCTKLWC TGKAKGQMVC
     QTRHFPWADG TSCGEGKLCL KGACVERHNL NKHRVDGSWA KWDPYGPCSR TCGGGVQLAR
     RQCTNPTPAN GGKYCEGVRV KYRSCNLEPC PSSASGKSFR EEQCEAFNGY NHSTNRLTLA
     VAWVPKYSGV SPRDKCKLIC RANGTGYFYV LAPKVVDGTL CSPDSTSVCV QGKCIKAGCD
     GNLGSKKRFD KCGVCGGDNK SCKKVTGLFT KPMHGYNFVV AIPAGASSID IRQRGYKGLI
     GDDNYLALKN SQGKYLLNGH FVVSAVERDL VVKGSLLRYS GTGTAVESLQ ASRPILEPLT
     VEVLSVGKMT PPRVRYSFYL PKEPREDKSS HPKDPRGPSV LHNSVLSLSN QVEQPDDRPP
     ARWVAGSWGP CSASCGSGLQ KRAVDCRGSA GQRTVPACDA AHRPVETQAC GEPCPTWELS
     AWSPCSKSCG RGFQRRSLKC VGHGGRLLAR DQCNLHRKPQ ELDFCVLRPC
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024